Global Wellness Corporate Quarter Highlights
Global Wellness Corporate Quarter Highlights
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") provides quarter corporate highlights.
温哥華,不列顛哥倫比亞省-(Newsfile Corp.-2022年6月27日)-全球健康戰略公司(CSE:GWS)(FSE:O3X4)(OTCQB:GWSFF)(“全球”或“公司”)提供本季度的企業亮點。
The Company quarter corporate highlights included announcing:
公司本季度的企業亮點包括宣佈:
May 12th that Global Wellness' Shanti Therapeutics was preparing for their first clinical trial with iNGENü a subsidiary of Australian leader Cannvalate. Shanti' s product suite of MDMA could be the global market winner finding a solution to the chronic puzzle of pain. iNGENü is engaged as the CRO (clinical research organization) by the Company to conduct clinical trials for Shanti Therapeutics. The protocol is a single center, randomized crossover study to investigate the efficacy of MDMA vs placebo in a model of experimental pain in healthy adults. Shanti has a targeted research pathway to clinical success, with strong proprietary protection under its already submitted patent providing a method for the treatment or prevention of pain. Plus May 9ththe Company announced the additional appointment to our advisory team of a chief medical advisor to assist with the Shanti Therapeutics acquisition.
五月十二日這是Global Wellness‘Shanti Treeutics正在準備與澳大利亞領軍企業Cannvalate的子公司Ingenü進行首次臨牀試驗. Shanti的MDMA系列產品可能成為全球市場的贏家,找到了解決長期痛苦之謎的辦法。Ingenü受聘為公司的CRO(臨牀研究機構),負責山體療法的臨牀試驗。該方案是一項單中心、隨機交叉研究,旨在研究MDMA與安慰劑在健康成年人實驗性疼痛模型中的療效。Shanti有一條通往臨牀成功的有針對性的研究途徑,其已經提交的專利提供了治療或預防疼痛的方法,具有強大的專利保護。加上5月9日這是該公司宣佈在我們的顧問團隊中額外任命一名首席醫療顧問,以協助收購Shanti Treateutics。
April 12th that the Global Wellness brand KaleidoMyco introduced their first ever effervescent tablets combining functional mushrooms and hemp extract. KaleidoMyco is focused on working with doctors and integrative medical practitioners in a collaborative effort in the discovery of products combining mycology formulas with hemp extract derived cannabinoids focused on health and wellness. Hemp infused medicinal mushroom products aka functional mushrooms are increasingly relevant, because of their ancient healing powers on an array of modern-day ailments. Taking these two powerful plant medicines together enables one to experience enhanced effects.
4月12日這是Global Wellness品牌KaleidoMyco推出了他們有史以來第一款結合功能性蘑菇和大麻提取物的泡騰片。KaleidoMyco專注於與醫生和綜合醫療從業者合作,共同努力發現將真菌學配方與大麻提取物衍生的大麻類化合物結合在一起的產品,專注於健康和健康。大麻浸泡的藥用蘑菇產品,也就是功能性蘑菇,越來越重要,因為它們對一系列現代疾病具有古老的治癒能力。將這兩種強大的植物藥物結合在一起可以使人體驗到增強的效果。
"Global Wellness will be focused this coming quarter on beginning the Shanti clinical trials and introducing new KaleidoMyco consumer product goods with a wider distribution network and revenues. Clearing our balance sheet of long-term debt and moving to a strong revenue model is key for us this quarter. The Company also recently announced our annual general meeting to be held August 18, 2022,'' stated Meris Kott, CEO Global Wellness Strategies Inc.
Global Wellness Strategy Inc.首席執行官Meris Kott表示:“Global Wellness在下個季度將專注於開始Shanti臨牀試驗,並推出具有更廣泛分銷網絡和收入的新KaleidoMyco消費品。清理我們的資產負債表中的長期債務並轉向強勁的收入模式是本季度的關鍵。公司最近還宣佈將於2022年8月18日舉行年度股東大會。”
Debt Settlement Updates:
債務結算更新:
The Company has issued a total of 1,850,000 common shares without par value in its capital (each, a "Share") to one non-arm's length creditor and an arm's length creditor of the Company at a deemed issuance price of $0.25 per Share.
本公司已向本公司一名非公平債權人及一名公平債權人發行合共1,850,000股無面值普通股(每股“股份”),每股視為發行價0.25美元。
The Company entered into a shares for debt settlement agreement with a current officer, pursuant to which the Company agreed to issue 850,000 common shares at a price of $0.25 per share in full settlement of accrued and outstanding indebtedness in the amount of $212,500 for the officer's fees owing. The insider settlement shares will be subject to a statutory hold period of four months from the date of issuance, in accordance with applicable policies of the Canadian Securities Exchange. The Company also entered into a debt settlement agreement with an arms-length consultant for the settlement of $250,000 in debt for professional and consulting services provided by the consultant to the Company. In settlement and full satisfaction of the debt the Company will issue 1,000,000 common shares at a deemed price of $0.25 per Share.
本公司與一名現任高級職員訂立股份債務清償協議,據此,本公司同意按每股0.25美元的價格發行850,000股普通股,以悉數清償該高級職員所欠的應計及未償還債務212,500元。根據加拿大證券交易所的適用政策,內幕和解股票將受到自發行之日起四個月的法定持有期的限制。本公司還與一名獨立顧問簽訂了一項債務清償協議,以清償該顧問向本公司提供的專業和諮詢服務所需的250,000美元債務。作為清償和全額清償債務,公司將以每股0.25美元的價格發行1,000,000股普通股。
The issuance of the settlement shares to the officer, also a director of the Company will be considered to be a "related party transaction" as defined under Multilateral Instrument 61-101. Protection of minority security holders in special transactions ("MI 61-101"); however, the issuances are exempt from the minority approval and formal valuation requirements of MI 61-101 pursuant to subsections 5.5(a) and 5.7(1)(a) of MI 61-101.
向該高級職員(亦為本公司的董事)發行結算股份,將被視為多邊文件61-101所界定的“關聯方交易”。在特別交易中對少數證券持有人的保護(“MI 61-101”);然而,根據MI 61-101第5.5(A)和5.7(1)(A)款的規定,發行的債券不受MI 61-101的少數股東批准和正式估值要求的約束。
About Global Wellness Strategies
關於全球健康戰略
Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies.
Global Wellness Strategy是一個前景創造者,在快速增長的健康消費品市場為高增長的公司提供財務、運營和管理方面的幫助。該公司專注於全球健康、迷幻藥、真菌學、大麻和CBD,以及與醫療保健相關的目標公司。
For further information visit websites:
欲瞭解更多信息,請訪問以下網站:
Or Contact Meris Kott CEO 604.484.0355 or email to info@globalwellnessstrategies.com
或聯繫Meris Kott首席執行官604.484.0355,或發送電子郵件至info@global alwell nessstrategies.com
Further information about the Company is available on under the Company's profile.
欲瞭解更多有關本公司的信息,請訪問:本公司簡介。
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute "forward-looking statements" or "forward-looking information" (collectively "forward-looking information") as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated", "anticipates" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
加拿大證券交易所及其監管服務提供商(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。本新聞稿中包含的某些陳述可能構成“前瞻性陳述”或“前瞻性信息”(統稱為“前瞻性信息”),因為這些術語在1995年的“私人證券訴訟改革法”和類似的加拿大法律中使用。這些陳述與未來的事件或未來的表現有關。使用“可能”、“打算”、“預期”、“相信”、“將”、“預計”、“估計”、“預期”以及與非歷史事實有關的類似表述和陳述,旨在識別前瞻性信息,並基於公司對此類未來事件的結果和時機的當前信念或假設。未來的實際結果可能會有很大不同。特別是,本新聞稿包含與該公司的業務、其融資和某些公司變化有關的前瞻性信息。本新聞稿中包含的前瞻性信息是截至本新聞稿發佈之日的信息,公司沒有義務因新信息、未來事件或其他原因而更新或修改任何前瞻性信息,除非適用的證券法要求這樣做。由於本文包含的風險、不確定性和假設,投資者不應過度依賴前瞻性信息。上述陳述明確表示,本文中包含的任何前瞻性信息都是合格的。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問
譯文內容由第三人軟體翻譯。